BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32146146)

  • 1. Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: Mutational analysis of putative regulatory binding motifs.
    Snyder AD; Ochs SD; Johnson BE; Sulentic CEW
    Mol Immunol; 2020 Apr; 120():164-178. PubMed ID: 32146146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region.
    Fernando TM; Ochs SD; Liu J; Chambers-Turner RC; Sulentic CE
    J Immunol; 2012 Apr; 188(7):3294-306. PubMed ID: 22357631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region.
    Salisbury RL; Sulentic CE
    Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.
    Henseler RA; Romer EJ; Sulentic CE
    Toxicology; 2009 Jun; 261(1-2):9-18. PubMed ID: 19447539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression.
    Zhang L; Savas U; Alexander DL; Jefcoate CR
    J Biol Chem; 1998 Feb; 273(9):5174-83. PubMed ID: 9478971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
    Sulentic CE; Holsapple MP; Kaminski NE
    J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific ligand binding domain residues confer low dioxin responsiveness to AHR1β of Xenopus laevis.
    Odio C; Holzman SA; Denison MS; Fraccalvieri D; Bonati L; Franks DG; Hahn ME; Powell WH
    Biochemistry; 2013 Mar; 52(10):1746-54. PubMed ID: 23394719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene.
    Wourms MJ; Sulentic CE
    Cell Immunol; 2015 May; 295(1):60-6. PubMed ID: 25749007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cellular and Molecular Determinants of Naphthoquinone-Dependent Activation of the Aryl Hydrocarbon Receptor.
    Faber SC; Giani Tagliabue S; Bonati L; Denison MS
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aryl hydrocarbon receptor homology model targeted to improve docking reliability.
    Motto I; Bordogna A; Soshilov AA; Denison MS; Bonati L
    J Chem Inf Model; 2011 Nov; 51(11):2868-81. PubMed ID: 21981577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide mapping and analysis of aryl hydrocarbon receptor (AHR)- and aryl hydrocarbon receptor repressor (AHRR)-binding sites in human breast cancer cells.
    Yang SY; Ahmed S; Satheesh SV; Matthews J
    Arch Toxicol; 2018 Jan; 92(1):225-240. PubMed ID: 28681081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aryl hydrocarbon receptor differentially modulates the expression profile of antibody isotypes in a human B-cell line.
    Bhakta-Yadav MS; Burra K; Alhamdan N; Allex-Buckner CP; Sulentic CEW
    Toxicol Sci; 2024 May; 199(2):276-288. PubMed ID: 38526216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
    Phadnis-Moghe AS; Crawford RB; Kaminski NE
    Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
    Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
    Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
    Williamson MA; Gasiewicz TA; Opanashuk LA
    Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-induction mechanism of aryl hydrocarbon receptor 2 (AHR2) gene by TCDD-activated AHR1 and AHR2 in the red seabream (Pagrus major).
    Bak SM; Iida M; Soshilov AA; Denison MS; Iwata H; Kim EY
    Arch Toxicol; 2017 Jan; 91(1):301-312. PubMed ID: 27188387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioxin activation of CYP1A5 promoter/enhancer regions from two avian species, common cormorant (Phalacrocorax carbo) and chicken (Gallus gallus): association with aryl hydrocarbon receptor 1 and 2 isoforms.
    Lee JS; Kim EY; Iwata H
    Toxicol Appl Pharmacol; 2009 Jan; 234(1):1-13. PubMed ID: 18948129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq.
    Lo R; Matthews J
    Toxicol Sci; 2012 Dec; 130(2):349-61. PubMed ID: 22903824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3'alpha immunoglobulin heavy chain enhancer.
    Sulentic CE; Kang JS; Na YJ; Kaminski NE
    Toxicology; 2004 Aug; 200(2-3):235-46. PubMed ID: 15212819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist.
    Faber SC; Soshilov AA; Giani Tagliabue S; Bonati L; Denison MS
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.